Acetylcholinesterase inhibition and protection by dizocilpine (MK-801) enantiomers

Journal of Pharmacy and Pharmacology

Volumn 48, Issue 1, 1996, Pages 71-76

  Galli, Alessandro ^a   Mori, Francesca ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; AMINO ACID RECEPTOR BLOCKING AGENT; BRAIN ENZYME; DIZOCILPINE; DYFLOS; ENZYME INHIBITOR; ORGANOPHOSPHATE;

ARTICLE; CHOLINESTERASE INHIBITION; COMPETITIVE INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENCY; ENANTIOMER; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; ISOMER; NONHUMAN; STRUCTURE ACTIVITY RELATION;

EID: 0029967825     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1996.tb05881.x     Document Type: Article

References (23)

1. Berman, H. A., Leonard, K. (1990) Ligand exclusion on acetylcholinesterase. Biochemistry 29: 10640-10649
2. Bigge, C. F. (1991) Structural requirements for the development of potent N-methyl-D-aspartic acid (NMDA) receptor antagonists. Biochem. Pharmacol. 45: 1547-1561
3. Clineschmidt, B. V., Martin, G. E., Bunting, P. R. (1982) Anticonvulsant activity of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5.10-imine maleate (MK-801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolitic properties. Drug Dev. Res. 2: 123-134
4. De Lean, A., Munson, P. J., Rodbard, D. (1978) Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay and physiological dose-response curves. Am. J. Physiol. 235: E97-E102
5. Dixon, M., Webb, E. C. (1979) Enzyme inhibition and activation. In: Dixon, M., Webb, E. C., Thorne, C. J. R. Tipton, K. F. (eds) Enzymes. 3rd edn, Longman, London, pp 332-467
6. Ellman, G. L., Courtney, K. D., Andres, V., Featherstone, R. M. (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7: 88-95
7. Galli, A., Mazri, A. (1988) Protection against diisopropylfluorophosphate intoxication by meptazinol. Toxicol. Appl. Pharmacol. 95: 388-396
8. Galli, A., Mori, F. (1991) Effectiveness of 1,2,3,4-tetrahydro-9-aminoacridine (THA) as a pretreatment drug for protection of mice from acute diisopropylfluorophosphate (DFP) intoxication. Arch. Toxicol. 65: 330-334
9. Galli, A., Mori, F., Gori, I., Lucherini, M. (1992) In vitro protection of acetylcholinesterase and butyrylcholinesterase by tetrahydroaminoacridine. Biochem. Pharmacol. 43: 2427-2433
10. Galli, A., Mori, F., Benini, L., Cacciarelli, N. (1994) Acetylcholinesterase protection and the anti-diisopropylfluorophosphate efficacy of E2020. Eur. J. Pharmacol. 270: 189-193
11. Goldberg, M. P., Visekul, V., Choi, D. W. (1988) Phencyclidine receptor ligands attenuate cortical neuronal injury after N-methyl-D-aspartate exposure or hypoxia. J. Pharmacol. Exp. Ther. 245: 1081-1092
12. Hobbiger, F. W. (1956) Chemical reactivation of phosphorylated human and bovine true cholinesterase. Br. J. Pharmacol. 11: 295-303
13. 3H]MK-801 at therapeutic concentrations in postmortem human frontal cortex. Eur. J. Pharmacol. 166: 589-590
14. Main, A. R. (1979) Mode of action of anticholinesterases Pharmacol. Ther. 6: 579-628
15. McLean, M. J., Gupta, R. C. Dettbarn, W.-D., Wamil, A. W. (1992) Prophylactic and therapeutic efficacy of memantine against seizures produced by soman in the rat. Toxicol. Appl. Pharmacol. 112: 95-103
16. Puu, G. (1988) Ketamine protects acetylcholinesterase against in vitro inhibition by sarin. Biochem. Pharmacol. 37: 969-970
17. Puu, G., Koch, M., Artursson, E. (1991) Ketamine enantiomers and acetylcholinesterase. Biochem. Pharmacol. 41: 2043-2045
18. Sparenborg, S., Brennecke, L. H., Jaax, N. K., Braitman, D. J. (1992) Dizocilpine (MK-801) arrests status epilepticus and prevents brain damage induced by soman. Neuropharmacol. 31: 357-368
19. Taylor, P., Lappi, S. (1975) Interaction of fluorescence probes with acetylcholinesterase: the site and specificity of propidium binding. Biochemistry 14: 1989-1997
20. Wills, J. H. (1970) Toxicities of anticholinesterases and its treatment. In: Karczmar, A. G. (ed.) Anticholinesterase Agents. International Encyclopedia of Pharmacology and Therapeutics, section 13. Pergamon Press, New York, pp 357-469
21. Wilson, I. B., Quan, C. (1958) Acetylcholinesterase on molecular complementariness. Arch. Biochem. Biophys. 73: 131-143
22. 3H]MK801 labels a site on the N-methyl-D-aspartate receptor channel complex in rat brain membranes. J. Neurochem. 50: 274-281
23. Wu, C-S.C., Yang, J. T. (1989) Tacrine protection of acetylcholinesterase from inactivation by diisopropylfluorophosphate: a circular dichroism study. Mol. Pharmacol. 35: 85-92